Hiromitsu Nakasa

712 citations
30 papers · 596 indexed · h-index 13

Hiromitsu Nakasa

29 papers receiving 581 citations

Peers

Hiromitsu Nakasa
Comparison fields: 5 of 79
  • Pharmacology 333
  • Oncology 210
  • Pediatrics, Perinatology and Child Health 111
  • Biochemistry 34
  • Endocrinology, Diabetes and Metabolism 67
Replace Wataru Kishimoto with:
Wataru Kishimoto Japan
Stephen Fowler Switzerland
Tsutomu Yoshimura Japan
Shingo Oda Japan
Catherine Spire France
Claire Belloc France
P. Marathe United States
Tetsuya Kamataki Japan
Yoshihiko Funae Japan
H. Noguchi Japan
Hiromitsu Nakasa relative to Wataru Kishimoto Japan Wataru Kishimoto's profile →
Citations per field
00.5×1.5×2.1×
Wataru Kishimoto · 1×
Citations per year

Countries citing papers authored by Hiromitsu Nakasa

Since Specialization
Citations

This map shows the geographic impact of Hiromitsu Nakasa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiromitsu Nakasa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiromitsu Nakasa more than expected).

Fields of papers citing papers by Hiromitsu Nakasa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiromitsu Nakasa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiromitsu Nakasa. The network helps show where Hiromitsu Nakasa may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Hiromitsu Nakasa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Hiromitsu Nakasa Line = papers co-authored together Hiromitsu Nakasa links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown
#Work
1 20240
2 20153
3 201010
4 200911
5 20083
6 20076
7 200669
8 200536
9 200464
10 200338
11 200214
12 20028
13 200123
14 19998
15 199861
16 199843
17 199413
18 19942
19 199352
20 199315

About Hiromitsu Nakasa

Hiromitsu Nakasa is a scholar working on Pharmacology, Pharmaceutical Science and Clinical Biochemistry, having authored 30 papers that have together received 596 indexed citations. Recurring topics across this work include Pharmacogenetics and Drug Metabolism (17 papers), Analytical Chemistry and Chromatography (4 papers), Drug Transport and Resistance Mechanisms (4 papers), Drug-Induced Hepatotoxicity and Protection (4 papers), Eicosanoids and Hypertension Pharmacology (3 papers), Chemical Reactions and Isotopes (3 papers), Metabolism and Genetic Disorders (2 papers) and Antimicrobial Resistance in Staphylococcus (2 papers). The work is most often cited by research in Pharmacology (333 citations), Oncology (210 citations) and Pediatrics, Perinatology and Child Health (111 citations). Hiromitsu Nakasa has collaborated with scholars based in Japan and United States. Frequent co-authors include Shigeru Ohmori, Hiroyoshi Nakamura, S. Ohmori, Itsuko Ishii, Mitsukazu Kitada, Munehiro Kitada, Mitsukazu Kitada, Noritaka Ariyoshi, Masahiro Kiuchi and Tadaaki Rikihisa. Their work appears in journals such as Archives of Biochemistry and Biophysics, Molecular Pharmacology and Pharmaceutical Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026